Clinical Trial: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)

Brief Summary: The purpose of this study is to determine whether Nelarabine is effective in the treatment of patients with T-ALL/NHL in order to achieve a complete remission followed by an early stem cell transplantation.

Detailed Summary:
Sponsor: Johann Wolfgang Goethe University Hospital

Current Primary Outcome: Tolerability and Efficacy of Compound GW506U78 in relapsed/refractory T-ALL/NHL [ Time Frame: after 1 cycle and 2 cycles ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Johann Wolfgang Goethe University Hospital

Dates:
Date Received: May 16, 2008
Date Started: June 2003
Date Completion:
Last Updated: August 20, 2010
Last Verified: May 2008